Newsletter Archive

1. 05.13.26 -- Simplify The Journey Of Advancing Your Therapies To Patients 5/13/2026

   05/13/26 Advancing RNA Newsletter

2. 05.02.26 -- Advancing RNA Newsletter Best Of April 5/2/2026
   05/02/26 Advancing RNA Newsletter
3. 04.29.26 -- Inside Alnylam's Playbook For High Volume siRNA Production 4/29/2026
   04/29/26 Advancing RNA Newsletter
4. 04.22.26 -- How Informal FDA Feedback Is Driving RNA Capital Allocation 4/22/2026
   04/22/26 Advancing RNA Newsletter
5. 04.16.26 -- Innovation That's Redefining Aseptic Filling 4/16/2026

   04/16/26 Advancing RNA Newsletter

6. 04.15.26 -- Defining Potency In The mRNA Space 4/15/2026
   04/15/26 Advancing RNA Newsletter
7. 04.08.26 -- Fact Checking The "Death" Of The US mRNA Industry 4/8/2026
   04/08/26 Advancing RNA Newsletter
8. 04.04.26 -- Advancing RNA Newsletter Best Of March 4/4/2026
   04/04/26 Advancing RNA Newsletter
9. 04.01.26 -- The Evolving CMC Landscape For mRNA-LNPs 4/1/2026
   04/01/26 Advancing RNA Newsletter
10. 03.25.26 -- Benchmarking RNA Delivery Performance: Toward Standardized Metrics For Translational Success 3/25/2026
    03/25/26 Advancing RNA Newsletter